IFNG and neoplasm: CD40 expression and IL‐12 release by NB supernatant-treated DCs are increased with exogenous IFN‐γ, indicating that a new type of tolerogenic DCs are active in NB TME and impair the anti-tumor effect of type 1 NKT cells (64).